Kiwi startup OpenStar's bold move to use levitating dipole reactor for fusion achieved a key milestone with its first plasma.

The 3,000-metre distillery has been unveils in the same year the New Zealand spirits brand celebrates a decade in business ...

Ormat Technologies has secured a contract for the development of the 101MW Te Mihi Stage 2 geothermal power plant in New ...

New Zealand’s banking landscape faces significant changes as new players target different segments, potentially disrupting ...

New Zealand food manufacturers are beginning to embrace the circular economy but are up against a lack of government support, ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

With no singular style and a range of microclimates, the one through line among distillers is a creative energy—and that they ...

Enter: “Your Cancer Is Our Challenge,” a new initiative that GSK unveiled Tuesday with an aim of raising awareness of and ...

Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...

The Mātai Medical Institute has already made waves with its MRI research, but if they have their way, this is just the beginning.